Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tessa I van Rijssel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|February 6, 2025
Diffused responsibilities in technology-driven health research: The case of artificial intelligence systems in decentralized clinical trialsSam H A Muller, Tessa I van Rijssel, Ghislaine J M W van Thiel, et al.
Health Care Analysis : HCA : Journal of Health Philosophy and Policy|May 19, 2024
The Ethics of Decentralized Clinical Trials and Informed Consent: Taking Technologies' Soft Impacts into AccountTessa I van Rijssel, Ghislaine J M W van Thiel, Johannes J M van Delden, et al.
The American Journal of Bioethics : AJOB|September 4, 2025
Which Benefits Can Justify Risks in Research? Response to Open Peer CommentariesTessa I van Rijssel, Ghislaine J M W van Thiel, Helga Gardarsdottir, et al.
The American Journal of Bioethics : AJOB|January 5, 2024
Which Benefits Can Justify Risks in Research?Tessa I van Rijssel, Ghislaine J M W van Thiel, Helga Gardarsdottir, et al.
BMC Medical Ethics|April 24, 2025
Diversity in decentralized clinical trials: prioritizing inclusion of underrepresented groupsTessa I van Rijssel, Johannes J M van Delden, Bart Lagerwaard, et al.
Drug Discovery Today|July 23, 2022
Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics reviewTessa I van Rijssel, Amos J de Jong, Yared Santa-Ana-Tellez, et al.
Clinical Pharmacology and Therapeutics|April 30, 2022
Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' PerspectiveAmos J de Jong, Tessa I van Rijssel, Mira G P Zuidgeest, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|February 6, 2025
Diffused responsibilities in technology-driven health research: The case of artificial intelligence systems in decentralized clinical trialsSam H A Muller, Tessa I van Rijssel, Ghislaine J M W van Thiel, et al.
Health Care Analysis : HCA : Journal of Health Philosophy and Policy|May 19, 2024
The Ethics of Decentralized Clinical Trials and Informed Consent: Taking Technologies' Soft Impacts into AccountTessa I van Rijssel, Ghislaine J M W van Thiel, Johannes J M van Delden, et al.
The American Journal of Bioethics : AJOB|September 4, 2025
Which Benefits Can Justify Risks in Research? Response to Open Peer CommentariesTessa I van Rijssel, Ghislaine J M W van Thiel, Helga Gardarsdottir, et al.
The American Journal of Bioethics : AJOB|January 5, 2024
Which Benefits Can Justify Risks in Research?Tessa I van Rijssel, Ghislaine J M W van Thiel, Helga Gardarsdottir, et al.
BMC Medical Ethics|April 24, 2025
Diversity in decentralized clinical trials: prioritizing inclusion of underrepresented groupsTessa I van Rijssel, Johannes J M van Delden, Bart Lagerwaard, et al.
Drug Discovery Today|July 23, 2022
Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics reviewTessa I van Rijssel, Amos J de Jong, Yared Santa-Ana-Tellez, et al.
Clinical Pharmacology and Therapeutics|April 30, 2022
Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' PerspectiveAmos J de Jong, Tessa I van Rijssel, Mira G P Zuidgeest, et al.
Pageof 1